Fotemustine, teniposide and dexamethasone versus high-dose methotrexate plus cytarabine in newly diagnosed primary CNS lymphoma: a randomised phase 2 trial

被引：0
|
作者：
Jingjing Wu
Lingling Duan
Lei Zhang
Zhenchang Sun
Xiaorui Fu
Xin Li
Ling Li
Xinhua Wang
Xudong Zhang
Zhaoming Li
Hui Yu
Yu Chang
Feifei Nan
Jiaqin Yan
Li Tian
Xiaoli Wang
Mingzhi Zhang
机构：
[1] The First Affiliated Hospital of Zhengzhou University,Department of Oncology, Lymphoma Diagnosis and Treatment Centre of Henan Province
来源：
Journal of Neuro-Oncology | 2018年 / 140卷
关键词：
Teniposide; Methotrexate; Primary CNS lymphoma; Chemotherapy; Whole-brain radiotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：427 / 434
页数：7
相关论文
共 50 条
  • [1] Fotemustine, teniposide and dexamethasone versus high-dose methotrexate plus cytarabine in newly diagnosed primary CNS lymphoma: a randomised phase 2 trial
    Wu, Jingjing
    Duan, Lingling
    Zhang, Lei
    Sun, Zhenchang
    Fu, Xiaorui
    Li, Xin
    Li, Ling
    Wang, Xinhua
    Zhang, Xudong
    Li, Zhaoming
    Yu, Hui
    Chang, Yu
    Nan, Feifei
    Yan, Jiaqin
    Tian, Li
    Wang, Xiaoli
    Zhang, Mingzhi
    JOURNAL OF NEURO-ONCOLOGY, 2018, 140 (02) : 427 - 434
  • [2] High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma
    Holdhoff, Matthias
    Ambady, Prakash
    Abdelaziz, Ahmed
    Sarai, Guneet
    Bonekamp, David
    Blakeley, Jaishri
    Grossman, Stuart A.
    Ye, Xiaobu
    NEUROLOGY, 2014, 83 (03) : 235 - 239
  • [3] High-dose methotrexate and rituximab with deferred radiotherapy for newly diagnosed primary B-cell CNS lymphoma
    Chamberlain, Marc C.
    Johnston, Sandra K.
    NEURO-ONCOLOGY, 2010, 12 (07) : 736 - 744
  • [4] First-line induction chemotherapy with high-dose methotrexate versus teniposide in patients with newly diagnosed primary central nervous system lymphoma: a retrospective, multicenter cohort study
    Zhong, Kaili
    Shi, Yanyan
    Gao, Yuhuan
    Zhang, Huilai
    Zhang, Mingzhi
    Zhang, Qiaohua
    Cen, Xinan
    Xue, Mei
    Qin, Yan
    Zhao, Yu
    Zhang, Liling
    Liang, Rong
    Wang, Ningju
    Xie, Yan
    Yang, Yu
    Liu, Aichun
    Bao, Huizheng
    Wang, Jingwen
    Cao, Baoping
    Zhang, Wei
    Zhang, Weijing
    BMC CANCER, 2023, 23 (01)
  • [5] Clinical outcomes of patients with newly diagnosed primary central nervous system lymphoma are comparable on treatment with high-dose methotrexate plus temozolomide and with high-dose methotrexate plus cytarabine: a single-institution experience
    Wang, Xiao-xiao
    Huang, Hui-qiang
    Bai, Bing
    Cai, Qing-qing
    Cai, Qi-chun
    Gao, Yan
    Xia, Yun-fei
    Xia, Zhong-jun
    Jiang, Wen-qi
    LEUKEMIA & LYMPHOMA, 2014, 55 (11) : 2497 - 2501
  • [6] High-dose cytarabine salvage therapy for recurrent primary CNS lymphoma
    Chamberlain, Marc C.
    JOURNAL OF NEURO-ONCOLOGY, 2016, 126 (03) : 545 - 550
  • [7] High-dose methotrexate for elderly patients with primary CNS lymphoma
    Zhu, Jay-Jiguang
    Gerstner, Elizabeth R.
    Engler, David A.
    Mrugala, Maciej M.
    Nugent, Whitney
    Nierenberg, Kristin
    Hochberg, Fred H.
    Betensky, Rebecca A.
    Batchelor, Tracy T.
    NEURO-ONCOLOGY, 2009, 11 (02) : 211 - 215
  • [8] First-line induction chemotherapy with high-dose methotrexate versus teniposide in patients with newly diagnosed primary central nervous system lymphoma: a retrospective, multicenter cohort study
    Kaili Zhong
    Yanyan Shi
    Yuhuan Gao
    Huilai Zhang
    Mingzhi Zhang
    Qiaohua Zhang
    Xinan Cen
    Mei Xue
    Yan Qin
    Yu Zhao
    Liling Zhang
    Rong Liang
    Ningju Wang
    Yan Xie
    Yu Yang
    Aichun Liu
    Huizheng Bao
    Jingwen Wang
    Baoping Cao
    Wei Zhang
    Weijing Zhang
    BMC Cancer, 23 (1)
  • [9] Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial
    Omuro, Antonio
    Chinot, Olivier
    Taillandier, Luc
    Ghesquieres, Herve
    Soussain, Carole
    Delwail, Vincent
    Lamy, Thierry
    Gressin, Remy
    Choquet, Sylvain
    Soubeyran, Pierre
    Huchet, Aymeri
    Benouaich-Amiel, Alexandra
    Lebouvier-Sadot, Sophie
    Gyan, Emmanuel
    Touitou, Valerie
    Barrie, Maryline
    del Rio, Monica Sierra
    Gonzalez-Aguilar, Alberto
    Houillier, Caroline
    Delgadillo, Daniel
    Lacomblez, Lucette
    Tanguy, Marie Laure
    Hoang-Xuan, Khe
    LANCET HAEMATOLOGY, 2015, 2 (06): : E251 - E259
  • [10] Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial
    Rajkumar, S. Vincent
    Jacobus, Susanna
    Callander, Natalie S.
    Fonseca, Rafael
    Vesole, David H.
    Williams, Michael E.
    Abonour, Rafat
    Siegel, David S.
    Katz, Michael
    Greipp, Philip R.
    LANCET ONCOLOGY, 2010, 11 (01) : 29 - 37
12345